| View |
|
BR-680
|
HEPATITIS B VACCINE (RECOMBINANT DNA )
|
Unbranded
|
20mcg/mL
|
Suspension For Injection (IM)
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
Renewal
|
01 March 2024
|
01 June 2029
|
| View |
|
BR-685
|
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
|
Synflorix
|
Each 0.5 mL dose contains:
1 mcg of polysaccharide for serotypes 1 1,2, 5 1,2, 6B 1,2, 7F1.2, 9V 1,2, 14 1,2 and 23F 1,2 and 3 mcg of serotypes 4 1,2, 18C 1,3, and 19F 1,4
'Adsorbed on aluminium phosphate 500 mcg A 13+ 2Conjugate to protein D (derived from Non-Typeable Haemophilus influenzae) carrier protein eq. to 9-16 mcg
3Conjugate to tetanus toxoid carrier protein eq. to 5-10 mcg
4Conjugate to diphtheria toxoid carrier protein e.q. to 3-6 mcg
|
Suspension for Injection (IM)
|
-
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
-
|
06 December 2019
|
26 June 2024
|
| View |
BR-689_PI_01.pdf
|
BR-689
|
Tocilizumab
|
Actemra
|
400 mg/ 20 mL
|
Concentrate For Solution For I.V. Infusion
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
Automatic Renewal
|
10 April 2023
|
20 March 2028
|
| View |
BR-690_PI_01.pdf
|
BR-690
|
Tocilizumab
|
Actemra
|
80 mg/ 4 mL
|
Concentrate For Solution For I.V. Infusion
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
Automatic Renewal
|
14 April 2023
|
20 March 2028
|
| View |
BR-691_PI_01.pdf
|
BR-691
|
Tocilizumab
|
Actemra
|
200 mg / 10 mL
|
Concentrate For Solution For I.V. Infusion
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
Automatic Renewal
|
09 April 2023
|
20 March 2028
|
| View |
|
BR-698
|
Filgrastim
|
Recombicyte
|
300mg/0.9mL
|
Solution for Injection (IV/SC)
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
27 April 2021
|
01 July 2026
|
| View |
|
BR-701
|
Epoetin Alfa
|
Eprex
|
4000 IU/0.4 mL
|
Solution For Injection (IV/SC)
|
-
|
Cilag AG
|
Switzerland
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-702
|
Epoetin Alfa
|
Eprex
|
10000 IU/mL
|
Solution For Injection (IV/SC)
|
-
|
Cilag AG
|
Switzerland
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-704
|
Epoetin Alfa
|
Eprex
|
40000 IU/mL
|
Solution For Injection (IV/SC)
|
-
|
Cilag AG
|
Switzerland
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-713
|
Recombinant Human Erythropoietin Alfa
|
Efotin
|
4000 IU/0.8mL
|
Solution For IV Injection
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
-
|
21 April 2021
|
11 February 2026
|
| View |
|
BR-714
|
Hepatitis B Vaccine (rDNA)
|
Euvax B (Adult) - Preservative Free
|
20 mcg/mL
|
Suspension For Injection (IM)
|
-
|
LG Chem, Ltd.
|
Korea
|
-
|
19 January 2022
|
15 February 2025
|
| View |
|
BR-715
|
Hepatitis B Vaccine (rDNA)
|
Euvax B (Pediatric) - Preservative Free
|
10 mcg/0.5 mL
|
Suspension For Injection (IM)
|
-
|
LG Chem, Ltd.
|
Korea
|
-
|
19 January 2022
|
15 February 2025
|
| View |
|
BR-718
|
Imiglucerase
|
Cerezyme
|
400 U
|
Power For Intravenous Infusion
|
-
|
Genzyme Ireland Limited
|
Ireland
|
Renewal
|
22 March 2022
|
10 June 2024
|
| View |
|
BR-724
|
Hepatitis B Vaccine (rDNA)
|
Revac-B+
|
20 mcg/mL
|
Solution For Injection (IM)
|
-
|
Bharat Biotech International Ltd.
|
India
|
-
|
08 March 2021
|
14 April 2025
|
| View |
|
BR-725
|
Hepatitis B Vaccine (Recombinant DNA)
|
Revac-B Mcf
|
10 mcg/0.5 mL
|
Suspension For Injection (IM)
|
-
|
Bharat Biotech International Limited
|
India
|
Renewal (Revalidation)
|
18 January 2023
|
14 April 2025
|
| View |
|
BR-727
|
Pneumococcal Vaccine, Polyvalent
|
Pneumovax 23
|
25mcg/0.5mL
|
Solution For Injection (I.M./ S.C.)
|
-
|
Merck Sharp & Dohme Corp.
|
U.S.A.
|
-
|
19 October 2020
|
20 April 2025
|
| View |
|
BR-733
|
Human Normal Immunoglobulin (IVIg)
|
Gamunex-C
|
10% (100 mg/mL)
|
Solution for Infusion (IV/SC)
|
-
|
Grifols Therapeutics LLC
|
U.S.A
|
-
|
27 April 2022
|
26 May 2027
|
| View |
|
BR-734
|
Epoeitin Alfa
|
Hemapo
|
10,000 IU/mL
|
Solution for Injection (IV/SC)
|
-
|
Center of Molecular Immunology (CIM)
|
Cuba
|
Renewal (Reconstruction)
|
17 June 2022
|
29 October 2024
|
| View |
|
BR-735
|
Epoeitin Alfa
|
Hemapo
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
-
|
Center of Molecular Immunology (CIM)
|
Cuba
|
Renewal (Reconstruction)
|
17 June 2022
|
29 October 2024
|
| View |
|
BR-737
|
Diphtheria and Tetanus Vaccine (Adsorbed)
|
SII TD-VAC
|
Formulation: Each dose (0.5 mL) contains: Diphtheria Toxoid.........<5 Lf 2 2 IU) Tetanus Toxoid................<5 Lf( 40 IU) Adsorbed on Aluminum Phosphate, Al3+.....................< 1.25 mg
|
Suspension for Injection (IM)
|
-
|
Serum Institute of India Pvt. Ltd.
|
India
|
Renewal
|
02 June 2022
|
27 April 2027
|